Brief: Palisade Bio Announces Pricing Of Upsized $120 Million Underwritten Public Offering Of Common Stock
01/10/2025 15:48
Oct 1 (Reuters) - Palisade Bio Inc PALI.O: PALISADE BIO ANNOUNCES PRICING OF UPSIZED $120 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK Source text: ID:nGNXb0MNxt Further company coverage: PALI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing